Still's disease is an acute systemic inflammatory illness that was first described in children but rarely also affects adults.' 2 Although fever, arthralgias/arthritis, myalgia, skin rash, lymphadenopathy, and sore throat are present in most patients, 3there are no pathognomonic symptoms or laboratory abnormalities for this disease and its incidence is probably underestimated, particularly in adults. A large number of diagnostic procedures are usually performed before diagnosis is made, and empirical treatment, particularly antibiotic, is often started in the assumption of an infectious disease. As a result, diagnosis and adequate treatment are usually delayed.
Among the typical features of Still's disease are increased laboratory inflammatory parameters; in one study abnormally high serum [tkat/l) (normal up to 240 U/ml), serum iron was reduced to 4 iimol/l, serum ferritin was extremely high with a value of 12 406 pg/l (normal 20-300 ,ug/i). Also, the soluble interleukin 2 receptor (sCD25) showed a striking increase up to 3200 U/ml (normal <930 U/ml (enzyme linked (fig 2) , and the patient is at present still in remission.
Discussion
Owing to the lack of pathognomonic symptoms and laboratory abnormalities, diagnosis of Still's disease is often difficult to establish, particularly when the disease occurs in adult life. It frequently is an exclusion diagnosis, which implies in many cases both a large number of needless investigations and a considerable delay in starting adequate treatment. Our report indicates that serum ferritin concentration can be used as a valuable marker, both as a diagnostic tool and as a treatment guideline for adult Still's disease.
The conditions in which serum ferritin has been reported to be markedly raised include malignancies, such as acute and chronic leukaemias, malignant lymphomas, melanoma, neuroblastoma and germ cell tumours, acute liver necrosis, and haemochromatosis (mostly conditions usually suggested by other clinical or laboratory findings)."8 Even in these conditions, however, serum ferritin concentrations rarely exceed values of 3000 [tg/l and values above 5000 [tg/l are extremely unusual. Besides being an important diagnostic tool, serum ferritin appears to be a reliable marker for monitoring disease activity and for guiding decisions about treatment, as exemplified by the one year follow up of our two patients. Certainly, ESR, CRP, and the soluble interleukin 2 receptor, which are greatly increased in active disease, can be used to assess disease activity, but the likelihood that these parameters are raised owing to intercurrent diseases is much higher than for ferritin. This may be clinically relevant particularly in patients receiving immunosuppressive therapy, as our patient 1. Recently, raised serum ferritin concentrations regulated pathway of enhanced ferritin synthesis may cause the moderately raised ferritinconcentrations found in haemochromatosis or related conditions, whereas direct activation through cytokines may be responsible for the extremely high ferritin concentrations that seem to be associated with Still's disease. In this respect it is interesting to note that our patient No 1 also had raised levels of soluble interleukin 2 receptor. Thus raised cytokine activity in Still's disease may be responsible for both clinical and laboratory findings. This is a testable hypothesis that may provide new clues to the pathogenesis of this intriguing disease.
